Search by Drug Name or NDC

    NDC 00088-2500-34 Apidra 100 [iU]/mL Details

    Apidra 100 [iU]/mL

    Apidra is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by sanofi-aventis U.S. LLC. The primary component is INSULIN GLULISINE.

    Product Information

    NDC 00088-2500
    Product ID 0088-2500_3ad0d2f5-b5e2-4da9-8b4a-29ca1338eaad
    Associated GPIs 27104004002022
    GCN Sequence Number 059985
    GCN Sequence Number Description insulin glulisine VIAL 100/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 25936
    HICL Sequence Number 033152
    HICL Sequence Number Description INSULIN GLULISINE
    Brand/Generic Brand
    Proprietary Name Apidra
    Proprietary Name Suffix n/a
    Non-Proprietary Name insulin glulisine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN GLULISINE
    Labeler Name sanofi-aventis U.S. LLC
    Pharmaceutical Class Insulin Analog [EPC], Insulin [Chemical/Ingredient]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA021629
    Listing Certified Through 2024-12-31

    Package

    NDC 00088-2500-34 (00088250034)

    NDC Package Code 0088-2500-34
    Billing NDC 00088250034
    Package 1 VIAL, GLASS in 1 CARTON (0088-2500-34) / 10 mL in 1 VIAL, GLASS
    Marketing Start Date 2009-02-24
    NDC Exclude Flag N
    Pricing Information N/A